Siirry päänavigointiin Siirry hakuun Siirry pääsisältöön

Breast cancer remodels lymphatics in sentinel lymph nodes

  • Dominik Eichin
  • , Diana Lehotina
  • , Anni Kauko
  • , Maki Uenaka
  • , Meri Leppänen
  • , Kati Elima
  • , Minna Piipponen
  • , Tapio Lönnberg
  • , Pia Boström
  • , Ilkka Koskivuo
  • , Tero Aittokallio
  • , Maija Hollmén
  • , Akira Takeda*
  • , Sirpa Jalkanen*
  • *Tämän työn vastaava kirjoittaja

Tutkimustuotos: LehtiartikkeliArtikkeliTieteellinenvertaisarvioitu

5 Sitaatiot (Scopus)
81 Lataukset (Pure)

Abstrakti

Cancer metastasis to sentinel lymph nodes (LNs) is often the first marker of potential disease progression. Although it is recognized that tumor-induced lymphangiogenesis facilitates metastasis into LNs in murine models, tumor-induced alterations in human lymphatic vessels remain obscure. Here we use single-cell RNA sequencing and high-resolution spatial transcriptomics to profile lymphatic endothelial cell (LEC) subsets in paired metastatic and non-metastatic LNs obtained from female patients with treatment-naïve breast cancer. Tumor metastasis decreases immunoregulatory LEC subsets, such as PD-L1+ subcapsular sinus LECs, while inducing an increase in capillary-like CD200+ HEY1+ LECs. Matrix Gla protein (MGP) is the most upregulated gene in metastatic LN LECs, and its expression on LECs is TGF-β and VEGF dependent. Upregulated MGP promotes cancer cell adhesion to LN lymphatics. Thus, breast cancer cell metastasis to LNs remodels LEC subsets in human LNs and escalates MGP expression, potentially facilitating cancer cell dissemination through the lymphatic system.

AlkuperäiskieliEnglanti
Artikkeli10056
JulkaisuNature Communications
Vuosikerta16
Numero1
DOI - pysyväislinkit
TilaJulkaistu - jouluk. 2025
OKM-julkaisutyyppiA1 Julkaistu artikkeli, soviteltu

Rahoitus

We thank Teppo Huttunen from Estimates for statistical analyses, Sari Mäki and Riikka Sjöroos for technical help, Joe Hettinger for revising the language, Bishwa Ghimire for his advice on bioinformatic analyses, Dinghao Zheng for running the Space Ranger pipeline, Damien Kaukonen for running the Space Ranger pipeline and statistical consultation, and Prof. Kari Alitalo for providing us with the anti-VEGFR3 antibody. This work was financed by the Research Council of Finland (A.T., M.H. and S.J.), the Finnish Cancer Foundation (M.H. and S.J.), Sigrid Juselius Foundation (A.T., M.H. and S.J.), Jane and Aatos Erkko Foundation (S.J.) and Sakari Alhopuro Foundation (A.T. and D.E.). The Turku Bioscience Centre Single-cell Omics Core Facility, the Finnish Functional Genomics Centre and Biocenter Finland are acknowledged for infrastructure support.

Sormenjälki

Sukella tutkimusaiheisiin 'Breast cancer remodels lymphatics in sentinel lymph nodes'. Ne muodostavat yhdessä ainutlaatuisen sormenjäljen.

Viittausmuodot